6-(Trifluoromethyl)pyrazine-2-carboxylic acid

Catalog No.: 
ACEMAP824
CAS No.: 
1060812-74-9
Molecular Formula: 
C6H3F3N2O2
Molecular Weight: 
192.10
6-(Trifluoromethyl)pyrazine-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$96.00In stockInquiry
250mg95%$148.00In stockInquiry
1g95%$377.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(Trifluoromethyl)pyrazine-2-carboxylic acid
IUPAC Name6-(trifluoromethyl)pyrazine-2-carboxylic acid
MDL No.MFCD13189474
Molecular FormulaC6H3F3N2O2
Molecular Weight192.10
SMILESO=C(C1=NC(C(F)(F)F)=CN=C1)O
InChI KeyXSTQESYINDCIJM-UHFFFAOYSA-N
SynonymAKOS017344904 | SCHEMBL1578654 | AB68479 | 6-trifluoromethyl-pyrazine-2-carboxylic acid | 6-Trifluoromethylpyrazine-2-carboxylic acid | FT-0730802 | D82843 | 6-(TRIFLUOROMETHYL)PYRAZINE-2-CARBOXYLIC ACID | EN300-125663 | MFCD13189474 | XSTQESYINDCIJM-UHFF
CAS No.1060812-74-9
PubChem CID56965588

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACEMAP824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDPQR264 route compound structure diagram
    ACDPQR2641644548-81-1In Stock
  2. Then
  3. ACEMAP824 route product structure diagram
    ACEMAP8241060812-74-9In Stock
Inquiry

2. ACEMAP824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEMAP824 route product structure diagram
    ACEMAP8241060812-74-9In Stock
Inquiry

3. ACEMAP824 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEMAP824 route product structure diagram
    ACEMAP8241060812-74-9In Stock
Inquiry

Comments (0)